716: Greg Meyers, Chief Digital and Technology Officer of Bristol Myers Squibb (BMS), discusses the innovations in digital health that he is driving and how they have accelerated the pace of drug discovery. He gives an overview of BMS's business and the company’s digital health program as well as how collaboration with physicians and hiring for various skills have been critical in developing game-changing innovations. Greg also covers the way his team collaborates internally across the silos within the organization and leverages technologies like artificial intelligence to increase the speed at which drugs are tested and developed. Finally, he explains why he chooses to immerse himself deeply in more technical aspects of the business, looks ahead at what trends in technology he believes will continue to make important contributions to healthcare, and reflects on the keys to his career success.